About AVT
Browse Articles
Authors
Customer Services

Original article

A systematic review of T-cell epitopes in hepatitis B virus: identification, genotypic variation and relevance to antiviral therapeutics

Christopher P Desmond, Angeline Bartholomeusz, Silvana Gaudieri, Peter A Revill, Sharon R Lewin

Corresponding author name: Sharon R Lewin
Corresponding author e-mail: s.lewin@alfred.org.au

Citation: Antiviral Therapy 2007; 13:161-175

Abstract

Background: The immune response to hepatitis B virus (HBV) is important for both viral control and disease pathogenesis. A detailed understanding of the HBV specificT-cell responses may potentially lead to novel therapeutic strategies for HBV.

Methods: All English language journal articles(including articles in press) up to October 2007 were retrieved using searches of MEDLINE, EMBASE and the Cochrane Controlled Trial Registry. An extensive database of HBV sequences (SeqHepB) and GenBank we reused to assess the degree of sequence variation in each epitope. The new standardized nomenclature for HBV amino acid position number was applied to all previously defined epitopes.

Results: Forty-four HBV-specific human leukocyte antigen (HLA) class I restricted and 32 HBV-specific HLA class II restricted epitopes have been defined and have been identified in all HBV genes. The majority of HLA class I restricted epitopes have been defined in HLA-A2-positive individuals in the setting of acute HBV infection. There is significant sequence variation of these epitopes within and between HBV genotypes. Newer HBV immunotherapeutics appear promising but are still in early phases of development.

Conclusions: Identification of HBV-specific epitopes innon-HLA-A2-positive individuals and recognition of genotypic variation across epitopes are important for the future development of novel immunotherapeutic strategies for the management of chronic HBV infection.

This manuscript has an Additional file.

<< BACK

Copyright © Nucleus Global 2014. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.